Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPROBE
NCT01968421Phase 4Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Mar 2015
- Primary completion
- Nov 2018
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-85 in bronchiectasis, sponsored by Chinese Academy of Medical Sciences. Started Mar 2015; status: completed.
02
Drugs
OM-85
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT01968421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968421.